RT Journal Article
SR Electronic
T1 Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0–2+) metastatic breast cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002194
DO 10.1136/jitc-2020-002194
VO 9
IS 6
A1 Lum, Lawrence G.
A1 Al-Kadhimi, Zaid
A1 Deol, Abhinav
A1 Kondadasula, Vidya
A1 Schalk, Dana
A1 Tomashewski, Elyse
A1 Steele, Patricia
A1 Fields, Kristie
A1 Giroux, Melissa
A1 Liu, Qin
A1 Flaherty, Lawrence
A1 Simon, Michael
A1 Thakur, Archana
YR 2021
UL http://jitc.bmj.com/content/9/6/e002194.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.